Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Non-Interventional Real-world Study Assessing the Effectiveness of Extrafine BDP/FF/G HS Single Inhaler Triple Therapy (SITT) on Symptom Scores in Asthma Patients After 6 Months Treatment

NCT07489911 is registered in ClinicalTrials.gov with Chiesi Slovenija, d.o.o. as lead sponsor.

NCT NCT07489911
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07489911 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Non-Interventional Real-world Study Assessing the Effectiveness of Extrafine BDP/FF/G HS Single Inhaler Triple Therapy (SITT) on Symptom Scores in Asthma Patients After 6 Months Treatment
Lead sponsor
Chiesi Slovenija, d.o.o.
Phase
Observational
Overall status
Recruiting
Start date
November 4, 2024
Completion date
July 31, 2026
Enrollment
200 (estimated)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

asthma, asthma bronchiale, asthma patients